These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 913751

  • 1. Genetic heterogeneity in thyrotoxicosis patients with and without endocrine ophthalmopathy.
    Schernthaner G, Ludwig H, Mayr WR, Höfer R.
    Diabete Metab; 1977 Sep; 3(3):189-92. PubMed ID: 913751
    [Abstract] [Full Text] [Related]

  • 2. HLA CW3 in thyrotoxicosis patients with and without endocrine ophthalmopathy.
    Mayr WR, Ludwig H, Schernthaner G, Höfer R.
    Tissue Antigens; 1976 Apr; 7(4):243-6. PubMed ID: 941129
    [Abstract] [Full Text] [Related]

  • 3. Lack of association between Hashimoto's thyroiditis and SD-locus HLA antigens.
    Ludwig H, Schernthaner G, Mayr WR, Höfer R.
    Diabete Metab; 1977 Jun; 3(2):127-30. PubMed ID: 578140
    [Abstract] [Full Text] [Related]

  • 4. Correlation of HLA and thyroid antibodies with clinical course of thyrotoxicosis treated with antithyroid drugs.
    Irvine WJ, Gray RS, Morris PJ, Ting A.
    Lancet; 1977 Oct 29; 2(8044):898-900. PubMed ID: 72241
    [Abstract] [Full Text] [Related]

  • 5. Increased susceptibility to endocrine opthalmopathy in HLA CW3 positive thyrotoxicosis patients [proceedings].
    Ludwig H, Schernthaner G, Mayr WR, Mehdi SQ.
    Diabete Metab; 1976 Sep 29; 2(3):163. PubMed ID: 1010142
    [No Abstract] [Full Text] [Related]

  • 6. Autoimmune thyroid disease: an integrated concept of Graves' and Hashimoto's diseases.
    Selenkow HA, Wyman P, Allweiss P.
    Compr Ther; 1984 Apr 29; 10(4):48-56. PubMed ID: 6373115
    [Abstract] [Full Text] [Related]

  • 7. Some immunological correlations between thyroid pathology and ophthalmopathy.
    Kandror V, Birjukova M, Kryukova I, Mkrtumova N, Konnova E.
    Exp Clin Endocrinol; 1991 May 29; 97(2-3):212-6. PubMed ID: 1915637
    [Abstract] [Full Text] [Related]

  • 8. HLA-DR associations with Graves' disease in eastern Hungary.
    Stenszky V, Kozma L, Balazs C, Farid NR.
    Clin Invest Med; 1983 May 29; 6(3):181-4. PubMed ID: 6580983
    [Abstract] [Full Text] [Related]

  • 9. Heterogeneity by cluster analysis techniques of Graves' patients typed for HLA DR and IgG heavy chain markers.
    Frecker MF, Preus M, Kozma L, Krasrits E, Stenszky V, Balazś C, Farid NR.
    Mol Biol Med; 1986 Feb 29; 3(1):63-71. PubMed ID: 3083192
    [Abstract] [Full Text] [Related]

  • 10. [Diabetes mellitus type I, thyroid gland autoimmunity, thyroid gland function and HLA status].
    Kehr S, Gastauer R, Winkler G.
    Monatsschr Kinderheilkd; 1985 Oct 29; 133(10):738-42. PubMed ID: 3906379
    [Abstract] [Full Text] [Related]

  • 11. [Value of the detection of antithyroid antibodies in thyroid pathology].
    Guillausseau C, Eyquem A, Vincens M, Laurent MF, Leger AF, Savoie JC.
    Pathol Biol (Paris); 1985 Jun 29; 33(6):653-8. PubMed ID: 3900884
    [Abstract] [Full Text] [Related]

  • 12. Evidence of a new antigen-antibody system (anti-Mic-1) in patients with systemic lupus erythematosus and hyperthyroidism.
    Salazar-Páramo M, García-de la Torre I, Hernández-Vazquez L, Ortíz-Cadena A.
    J Rheumatol; 1989 Feb 29; 16(2):175-80. PubMed ID: 2746564
    [Abstract] [Full Text] [Related]

  • 13. [HLA typing and insulin antibody production in insulin-dependent diabetics].
    Bruni B, Barolo P, Gadaleta G, Gamba Ansaldi S, Grassi G, Zerbinati A, Molinatti M, Salvetti E.
    Ann Osp Maria Vittoria Torino; 1984 Feb 29; 27(7-12):185-213. PubMed ID: 6443704
    [Abstract] [Full Text] [Related]

  • 14. [HLA class I and II antigens and diffuse toxic goiter].
    Kalinin AP, Kamynina TS, Zaretskaia IuM, Abramov VIu, Klinova EG, Karachintsev VI.
    Ter Arkh; 1993 Feb 29; 65(3):81-5. PubMed ID: 8059394
    [Abstract] [Full Text] [Related]

  • 15. Decreased incidence of HLA-A11 and increased incidence of HLA-B8 in a North American population of insulin dependent diabetics.
    Slater LM, Kershnar A, Golden M, Mosier MA, Arquilla ER.
    J Clin Lab Immunol; 1980 Sep 29; 4(2):91-4. PubMed ID: 7003149
    [Abstract] [Full Text] [Related]

  • 16. HLA, Gm and endocrine diseases.
    Herzog P, Felt V, Májský A, Cenková V.
    Czech Med; 1984 Sep 29; 7(2):117-21. PubMed ID: 6589149
    [Abstract] [Full Text] [Related]

  • 17. Effect of HLA-DR positive thyrocytes on in vitro thyroid autoantibody production.
    Iwatani Y, Iitaka M, Row VV, Volpé R.
    Clin Invest Med; 1988 Aug 29; 11(4):279-85. PubMed ID: 3262474
    [Abstract] [Full Text] [Related]

  • 18. Two sisters, one with Graves' disease and the second with thyroiditis and transient hyperthyroidism.
    Tong A, Farid NR, Stenszky V.
    Acta Med Acad Sci Hung; 1982 Aug 29; 39(1-2):7-10. PubMed ID: 6897475
    [No Abstract] [Full Text] [Related]

  • 19. HLA CW3 and HLA CW4 have a protective effect on acquisition of chronic myeloid leukemia on Mexican patients.
    Rosas-Cabral A, Irigoyen L, Alvarado L, Vela-Ojeda J, Ayala-Sánchez M, Tripp-Villanueva F, Sánchez E, Gonzalez-Llaven J, Gariglio P.
    Rev Invest Clin; 2003 Aug 29; 55(4):423-8. PubMed ID: 14635607
    [Abstract] [Full Text] [Related]

  • 20. Carcinoembryonic antigen and humoral antibody response in patients with thyroid carcinoma.
    Rochman H, deGroot LJ, Rieger CH, Varnavides LA, Refetoff S, Joung JI, Hoye K.
    Cancer Res; 1975 Oct 29; 35(10):2689-92. PubMed ID: 1157044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.